Opisthorchiasis Treatment

A Global Strategic Business Report

MCP37590

RESEARCH DASHBOARD

OCT 2025

RELEASE DATE

7092

EXECUTIVE POOL

5850

PRICE

994

EXPERT INPUTS

32

COMPANIES

414

DATA TABLES

476

PAGES

2

EDITION

WHAT'S BEHIND OUR DATA?

140857226

DOMAIN TRANSCRIPTS

6080276

BRANDS TRACKED

1729341

FEATURED COMPANIES

22574

TOPICS COVERED

82719

MARKET SEGMENTS

91

KEY INDUSTRIES

1574

CURATION TEAM

4761909

DECISION MAKERS

EXECUTIVE ENGAGEMENTS BY TIER (55)

3

CXO

5

VICE PRESIDENT

10

DIRECTOR

25

MANAGER

12

MARKETING

REQUEST FULL-STACK INDEX Includes 350+ pages validated sources

QUESTIONNAIRE EXECUTIVES DATA ROOM

OUR EXPERT PANELS

Panelists are carefully chosen based on their domain expertise and market influence.

Participation in our expert panels is only by invitation. Our project focused panels are constituted of senior executives in business strategy, marketing, sales, and product management at competitive companies worldwide. We also welcome individuals from leading management consulting, venture capital, private equity, investment management and related firms with domain expertise and are actively monitoring specific companies or industries. Our panelists bring unique market perspectives and unbiased intelligence to our ongoing research programs.

INFLUENCER INVITEE

WHY PARTICIPATE?

Expertise to the Power of YOU!

Collaborative Insights - Expand your deep domain insights from participants at competitive companies worldwide while you share your own!
Global Acumen Alerts - Expand your intelligence on your areas of interest by enabling our “Email Alerts” feature drawing from other influencers’ project participation.
Enterprise-wide Project Discounts - Discounts start @ 10% and build up as more participants support our ongoing projects in your space.
Complimentary Copies - We highly recommend collaboration with your team to draw upon their geographical domain expertise. Our platform enables collaborative engagements with 10 peers. When you or any of your team members purchase the report, the entire team will receive complimentary copies with full stack access to our data and updates for one year.
Annual Digital Subscription to one of the business publications or $100 value gift card - No Purchase Required! The lead participant will receive the digital subscription

The Economist
MIT Technology Review
Harvard Business Review

Note - Offer is limited to one participant per company. Offer may be withdrawn at anytime without notice once our annual maximum participation of leading players is fulfilled. Offer by invitation only, to enterprise executives in from companies featured in the project ranked. If you’ve received our initation, you’re qualified! If not, you may check your eligibility by registering to join our Project Expert Panel. Typically you must be have a Marketing, Strategy, Product Management or Business Development, role as a CXO or VP or Director or Manager directly involved with the P&L of the products or services covered in the report. You must complete all modules in the Primary Research Data Simulator.

MARKETGLASS

BASIC

Annual Prepaid Subscription
Single-User
10,000 Data Room Credits/Month
Research Tool - Unlimited Access to Build Your Own Search Engine Data & Domain Expert Video Transcriptions.
Use MarketGlass^TM Data Templates For Your Own Enterprise Data to Build Bespoke Research Reports.
My Silo - Build Your Private Data Room for Generative AI and Other Applications. Download Data Stacks For External Applications & Language Models.

PREMIUM

Annual Prepaid Subscription
One Research Project With One Complimentary Update/Year
10-User License
10-User Peer-to-Peer Collaborative Features
200 Domain Expert Insights (With Name, Company, and Date)
50,000 Data Room Credits
Research Tool - Unlimited Access to Build Your Own Search Engine Data & Domain Expert Video Transcriptions.
Use Publisher's Market Data Templates to Simulate & Build Your Bespoke Variations to Published Data (4 Reports/Year)
Use Your Own Data and MarketGlass^TM Data Room Content.
My Silo - Build Your Private Data Room for Generative AI and Other Applications. Download Data Stacks For External Applications & Language Models.
Add Extra Topics/Reports During The Year At Regular Prices With Full Platform Privileges

ENTERPRISE

Annual Prepaid Subscription
Four Research Projects With One Complimentary Update/Year
25-User License
25-User Peer-to-Peer Collaborative Engagements
500 Domain Expert Insights (With Name, Company, and Date)
150,000 Data Room Credits
Research Tool - Unlimited Access to Build Your Own Search Engine Data & Domain Expert Video Transcriptions.
Use Publisher's Market Data Templates to Simulate & Build Your Bespoke Variations to Published Data (4 Reports/Year)
Use Your Own Data and MarketGlass^TM Data Room Content.
My Silo - Build Your Private Data Room for Generative AI and Other Applications. Download Data Stacks For External Applications & Language Models.
Add Extra Topics/Reports During The Year At Regular Prices With Full Platform Privileges

HIGHLIGHTS & REPORT INDEX

Global Opisthorchiasis Treatment Market to Reach US$504.6 Million by 2030

The global market for Opisthorchiasis Treatment estimated at US$389.5 Million in the year 2024, is expected to reach US$504.6 Million by 2030, growing at a CAGR of 4.4% over the analysis period 2024-2030. Medications Type, one of the segments analyzed in the report, is expected to record a 3.6% CAGR and reach US$323.2 Million by the end of the analysis period. Growth in the Surgery Type segment is estimated at 6.0% CAGR over the analysis period.

The U.S. Market is Estimated at US$106.1 Million While China is Forecast to Grow at 6.9% CAGR

The Opisthorchiasis Treatment market in the U.S. is estimated at US$106.1 Million in the year 2024. China, the world`s second largest economy, is forecast to reach a projected market size of US$97.6 Million by the year 2030 trailing a CAGR of 6.9% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.1% and 4.4% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.8% CAGR.

Global Opisthorchiasis Treatment Landscape - Key Trends & Drivers Summarized

Why Is Opisthorchiasis a Public Health Concern and What Triggers the Need for Treatment?

Opisthorchiasis is a parasitic infection caused by liver flukes, primarily Opisthorchis viverrini and Opisthorchis felineus, acquired through consumption of raw or undercooked freshwater fish. The disease is endemic in regions of Southeast Asia, Eastern Europe, and parts of Siberia. Chronic infections can persist for decades, damaging the liver, gallbladder, and bile ducts. Over time, they can lead to severe complications such as cholangitis, cholecystitis, and a heightened risk of cholangiocarcinoma.

Widespread consumption of traditional raw fish dishes in endemic areas sustains transmission. Infected individuals may remain asymptomatic for years, contributing to underdiagnosis and delayed treatment. Once symptoms emerge, they may include abdominal pain, fatigue, indigestion, and hepatobiliary abnormalities. Increasing awareness of liver fluke-related complications and broader surveillance programs are prompting healthcare providers to pursue early intervention strategies. Accurate diagnosis, typically based on stool microscopy or advanced antigen detection methods, is critical for timely treatment.

What Therapies Are Available and How Effective Are They in Clinical Practice?

The primary pharmacological treatment for opisthorchiasis is praziquantel, a broad-spectrum antiparasitic agent administered in short-course regimens. It acts by disrupting calcium ion balance in the parasites, causing paralysis and death. Treatment is generally effective, with high cure rates and good tolerability. In some settings, albendazole is considered as an alternative, though it is typically less effective against Opisthorchis species. Repeat treatment may be required in cases of high parasite burden or reinfection.

Symptomatic management may be necessary in advanced cases involving biliary tract inflammation or fibrosis. Supportive therapies may include antispasmodics, hepatoprotective agents, and bile flow regulators. Surgical interventions may be required in cases involving complications such as gallstones or bile duct obstruction. Long-term follow-up is recommended for patients with repeated infections due to elevated risk of hepatobiliary cancers. Integration of antiparasitic treatment with public health interventions, such as mass drug administration campaigns, has been shown to reduce infection prevalence in endemic communities.

What Preventive and Systemic Measures Are Shaping Treatment Strategies?

Efforts to control opisthorchiasis are increasingly combining therapeutic intervention with public health education and food safety campaigns. Promotion of safe food preparation practices, especially discouraging consumption of raw or fermented freshwater fish, plays a critical role in reducing transmission. Community-wide deworming programs have been implemented in several endemic countries, supported by school-based screening and national control strategies.

Improvements in water sanitation, health education, and access to diagnostics are reinforcing treatment effectiveness. Research is ongoing into potential vaccines and more selective anthelmintic agents with improved safety profiles, especially for children and vulnerable populations. Enhanced surveillance systems, supported by digital tools and geospatial mapping, are enabling targeted intervention and outbreak containment. Partnerships between health ministries and international health organizations are contributing to long-term disease control objectives.

What Factors Are Driving Growth in the Opisthorchiasis Treatment Market?

Growth in the opisthorchiasis treatment market is driven by several factors. Persistent endemicity in parts of Asia and Eastern Europe is maintaining demand for diagnostic and therapeutic services. Increasing incidence of hepatobiliary diseases linked to chronic infection is prompting earlier medical intervention. Availability of effective, affordable anthelmintic drugs such as praziquantel is facilitating mass treatment initiatives. Expansion of public health infrastructure and disease monitoring programs is enabling broader access to care in rural and underserved areas. Rising awareness of foodborne parasitic risks and integration of treatment into national disease control frameworks are supporting consistent demand. These factors are collectively reinforcing the importance of timely, accessible, and community-level treatment strategies in managing opisthorchiasis globally.

SCOPE OF STUDY

The report analyzes the Opisthorchiasis Treatment market by the following Segments, and Geographic Regions/Countries:

Segments:

Type (Medications Type, Surgery Type); Diagnostic Procedure (Cholangiography Diagnostic Procedure, MRI Diagnostic Procedure, Ultrasonography Diagnostic Procedure, CT scan Diagnostic Procedure, Other Diagnostic Procedures); Symptom (Jaundice Symptom, Diarrhea Symptom, Fever Symptom, Splenomegaly Symptom, Weight loss Symptom, Tachycardia Symptom, Other Symptoms); End-Use (Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use, Other End-Uses).

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa..

SELECT PLAYERS

AbbVie; Astellas Pharma; Bayer AG; Boehringer Ingelheim; Cipla Inc.; Eli Lilly and Company; F. Hoffmann-La Roche; Gilead Sciences; GlaxoSmithKline plc; Hubei Zhongjia-Chem Pharmaceutical; Johnson & Johnson; Merck KGaA; Merck Sharp & Dohme (MSD); Mankind Pharma; Novartis AG; Pfizer Inc.; Sanofi; Shin Poong Pharmaceutical Co., Ltd.; Sun Pharmaceutical Industries; Teva Pharmaceutical Industries Ltd.;

AI INTEGRATIONS

We’re transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

Trade Shocks, Uncertainty, and the Structural Rewiring of the Global Economy

World Market Trajectories

How Trump’s Tariffs Impact the Market? The Big Question on Everyone’s Mind

Opisthorchiasis Treatment – Global Key Competitors Percentage Market Share in 2025 (E)

Competitive Market Presence - Strong/Active/Niche/Trivial for 32 Players Worldwide in 2025 (E)

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

Rising Prevalence of Foodborne Parasitic Infections in Southeast Asia Drives Demand for Opisthorchiasis Treatment Protocols

Expansion of Public Health Surveillance Programs Strengthens Early Detection and Community-Based Case Management

Increased Availability and Distribution of Antiparasitic Drugs Like Praziquantel Support Scalable Treatment Coverage

Growth in Awareness Campaigns on Raw Fish Consumption Risks Spurs Preventive Screening and Early Therapeutic Intervention

Integration of Diagnosis and Treatment Through Primary Care Networks Enhances Reach in Endemic Rural Areas

Support from Global Health Organizations for Helminthic Disease Control Accelerates Drug Access and Treatment Infrastructure

Advancements in Molecular Diagnostics and ELISA-Based Tests Improve Detection of Low-Intensity and Asymptomatic Infections

Development of Drug Resistance Monitoring Systems Strengthens Sustainability of Current First-Line Therapies

Expansion of School-Based Deworming Programs Includes Opportunistic Screening for Liver Fluke Infections

4. GLOBAL MARKET PERSPECTIVE

World Opisthorchiasis Treatment Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030

World Recent Past, Current & Future Analysis for Opisthorchiasis Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR

World Historic Review for Opisthorchiasis Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR

World 16-Year Perspective for Opisthorchiasis Treatment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2025 & 2030

World Recent Past, Current & Future Analysis for Medications Type by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR

World Historic Review for Medications Type by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR

World 16-Year Perspective for Medications Type by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030

World Recent Past, Current & Future Analysis for Surgery Type by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR

World Historic Review for Surgery Type by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR

World 16-Year Perspective for Surgery Type by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030

World Recent Past, Current & Future Analysis for Fever Symptom by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR

World Historic Review for Fever Symptom by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR

World 16-Year Perspective for Fever Symptom by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030

World Recent Past, Current & Future Analysis for Splenomegaly Symptom by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR

World Historic Review for Splenomegaly Symptom by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR

World 16-Year Perspective for Splenomegaly Symptom by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030

World Recent Past, Current & Future Analysis for Weight loss Symptom by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR

World Historic Review for Weight loss Symptom by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR

World 16-Year Perspective for Weight loss Symptom by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030

World Recent Past, Current & Future Analysis for Tachycardia Symptom by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR

World Historic Review for Tachycardia Symptom by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR

World 16-Year Perspective for Tachycardia Symptom by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030

World Recent Past, Current & Future Analysis for Other Symptoms by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR

World Historic Review for Other Symptoms by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR

World 16-Year Perspective for Other Symptoms by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030

World Recent Past, Current & Future Analysis for Jaundice Symptom by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR

World Historic Review for Jaundice Symptom by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR

World 16-Year Perspective for Jaundice Symptom by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030

World Recent Past, Current & Future Analysis for Diarrhea Symptom by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR

World Historic Review for Diarrhea Symptom by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR

World 16-Year Perspective for Diarrhea Symptom by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030

World Recent Past, Current & Future Analysis for Hospitals & Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR

World Historic Review for Hospitals & Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR

World 16-Year Perspective for Hospitals & Clinics End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030

World Recent Past, Current & Future Analysis for Ambulatory Surgery Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR

World Historic Review for Ambulatory Surgery Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR

World 16-Year Perspective for Ambulatory Surgery Centers End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030

World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR

World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR

World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030

World Recent Past, Current & Future Analysis for Cholangiography Diagnostic Procedure by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR

World Historic Review for Cholangiography Diagnostic Procedure by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR

World 16-Year Perspective for Cholangiography Diagnostic Procedure by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030

World Recent Past, Current & Future Analysis for MRI Diagnostic Procedure by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR

World Historic Review for MRI Diagnostic Procedure by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR

World 16-Year Perspective for MRI Diagnostic Procedure by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030

World Recent Past, Current & Future Analysis for Ultrasonography Diagnostic Procedure by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR

World Historic Review for Ultrasonography Diagnostic Procedure by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR

World 16-Year Perspective for Ultrasonography Diagnostic Procedure by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030

World Recent Past, Current & Future Analysis for CT scan Diagnostic Procedure by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR

World Historic Review for CT scan Diagnostic Procedure by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR

World 16-Year Perspective for CT scan Diagnostic Procedure by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030

World Recent Past, Current & Future Analysis for Other Diagnostic Procedures by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR

World Historic Review for Other Diagnostic Procedures by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR

World 16-Year Perspective for Other Diagnostic Procedures by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030

III. MARKET ANALYSIS

UNITED STATES

Opisthorchiasis Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)

USA Recent Past, Current & Future Analysis for Opisthorchiasis Treatment by Type - Medications Type and Surgery Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

USA Historic Review for Opisthorchiasis Treatment by Type - Medications Type and Surgery Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR

USA 16-Year Perspective for Opisthorchiasis Treatment by Type - Percentage Breakdown of Value Sales for Medications Type and Surgery Type for the Years 2014, 2025 & 2030

USA Recent Past, Current & Future Analysis for Opisthorchiasis Treatment by Symptom - Fever Symptom, Splenomegaly Symptom, Weight loss Symptom, Tachycardia Symptom, Other Symptoms, Jaundice Symptom and Diarrhea Symptom - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

USA Historic Review for Opisthorchiasis Treatment by Symptom - Fever Symptom, Splenomegaly Symptom, Weight loss Symptom, Tachycardia Symptom, Other Symptoms, Jaundice Symptom and Diarrhea Symptom Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR

USA 16-Year Perspective for Opisthorchiasis Treatment by Symptom - Percentage Breakdown of Value Sales for Fever Symptom, Splenomegaly Symptom, Weight loss Symptom, Tachycardia Symptom, Other Symptoms, Jaundice Symptom and Diarrhea Symptom for the Years 2014, 2025 & 2030

USA Recent Past, Current & Future Analysis for Opisthorchiasis Treatment by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

USA Historic Review for Opisthorchiasis Treatment by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR

USA 16-Year Perspective for Opisthorchiasis Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030

USA Recent Past, Current & Future Analysis for Opisthorchiasis Treatment by Diagnostic Procedure - Cholangiography Diagnostic Procedure, MRI Diagnostic Procedure, Ultrasonography Diagnostic Procedure, CT scan Diagnostic Procedure and Other Diagnostic Procedures - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

USA Historic Review for Opisthorchiasis Treatment by Diagnostic Procedure - Cholangiography Diagnostic Procedure, MRI Diagnostic Procedure, Ultrasonography Diagnostic Procedure, CT scan Diagnostic Procedure and Other Diagnostic Procedures Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR

USA 16-Year Perspective for Opisthorchiasis Treatment by Diagnostic Procedure - Percentage Breakdown of Value Sales for Cholangiography Diagnostic Procedure, MRI Diagnostic Procedure, Ultrasonography Diagnostic Procedure, CT scan Diagnostic Procedure and Other Diagnostic Procedures for the Years 2014, 2025 & 2030

CANADA

Canada Recent Past, Current & Future Analysis for Opisthorchiasis Treatment by Type - Medications Type and Surgery Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Canada Historic Review for Opisthorchiasis Treatment by Type - Medications Type and Surgery Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR

Canada 16-Year Perspective for Opisthorchiasis Treatment by Type - Percentage Breakdown of Value Sales for Medications Type and Surgery Type for the Years 2014, 2025 & 2030

Canada Recent Past, Current & Future Analysis for Opisthorchiasis Treatment by Symptom - Fever Symptom, Splenomegaly Symptom, Weight loss Symptom, Tachycardia Symptom, Other Symptoms, Jaundice Symptom and Diarrhea Symptom - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Canada Historic Review for Opisthorchiasis Treatment by Symptom - Fever Symptom, Splenomegaly Symptom, Weight loss Symptom, Tachycardia Symptom, Other Symptoms, Jaundice Symptom and Diarrhea Symptom Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR

Canada 16-Year Perspective for Opisthorchiasis Treatment by Symptom - Percentage Breakdown of Value Sales for Fever Symptom, Splenomegaly Symptom, Weight loss Symptom, Tachycardia Symptom, Other Symptoms, Jaundice Symptom and Diarrhea Symptom for the Years 2014, 2025 & 2030

Canada Recent Past, Current & Future Analysis for Opisthorchiasis Treatment by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Canada Historic Review for Opisthorchiasis Treatment by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR

Canada 16-Year Perspective for Opisthorchiasis Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030

Canada Recent Past, Current & Future Analysis for Opisthorchiasis Treatment by Diagnostic Procedure - Cholangiography Diagnostic Procedure, MRI Diagnostic Procedure, Ultrasonography Diagnostic Procedure, CT scan Diagnostic Procedure and Other Diagnostic Procedures - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Canada Historic Review for Opisthorchiasis Treatment by Diagnostic Procedure - Cholangiography Diagnostic Procedure, MRI Diagnostic Procedure, Ultrasonography Diagnostic Procedure, CT scan Diagnostic Procedure and Other Diagnostic Procedures Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR

Canada 16-Year Perspective for Opisthorchiasis Treatment by Diagnostic Procedure - Percentage Breakdown of Value Sales for Cholangiography Diagnostic Procedure, MRI Diagnostic Procedure, Ultrasonography Diagnostic Procedure, CT scan Diagnostic Procedure and Other Diagnostic Procedures for the Years 2014, 2025 & 2030

JAPAN

Opisthorchiasis Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)

Japan Recent Past, Current & Future Analysis for Opisthorchiasis Treatment by Type - Medications Type and Surgery Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Japan Historic Review for Opisthorchiasis Treatment by Type - Medications Type and Surgery Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR

Japan 16-Year Perspective for Opisthorchiasis Treatment by Type - Percentage Breakdown of Value Sales for Medications Type and Surgery Type for the Years 2014, 2025 & 2030

Japan Recent Past, Current & Future Analysis for Opisthorchiasis Treatment by Symptom - Fever Symptom, Splenomegaly Symptom, Weight loss Symptom, Tachycardia Symptom, Other Symptoms, Jaundice Symptom and Diarrhea Symptom - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Japan Historic Review for Opisthorchiasis Treatment by Symptom - Fever Symptom, Splenomegaly Symptom, Weight loss Symptom, Tachycardia Symptom, Other Symptoms, Jaundice Symptom and Diarrhea Symptom Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR

Japan 16-Year Perspective for Opisthorchiasis Treatment by Symptom - Percentage Breakdown of Value Sales for Fever Symptom, Splenomegaly Symptom, Weight loss Symptom, Tachycardia Symptom, Other Symptoms, Jaundice Symptom and Diarrhea Symptom for the Years 2014, 2025 & 2030

Japan Recent Past, Current & Future Analysis for Opisthorchiasis Treatment by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Japan Historic Review for Opisthorchiasis Treatment by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR

Japan 16-Year Perspective for Opisthorchiasis Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030

Japan Recent Past, Current & Future Analysis for Opisthorchiasis Treatment by Diagnostic Procedure - Cholangiography Diagnostic Procedure, MRI Diagnostic Procedure, Ultrasonography Diagnostic Procedure, CT scan Diagnostic Procedure and Other Diagnostic Procedures - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Japan Historic Review for Opisthorchiasis Treatment by Diagnostic Procedure - Cholangiography Diagnostic Procedure, MRI Diagnostic Procedure, Ultrasonography Diagnostic Procedure, CT scan Diagnostic Procedure and Other Diagnostic Procedures Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR

Japan 16-Year Perspective for Opisthorchiasis Treatment by Diagnostic Procedure - Percentage Breakdown of Value Sales for Cholangiography Diagnostic Procedure, MRI Diagnostic Procedure, Ultrasonography Diagnostic Procedure, CT scan Diagnostic Procedure and Other Diagnostic Procedures for the Years 2014, 2025 & 2030

CHINA

Opisthorchiasis Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)

China Recent Past, Current & Future Analysis for Opisthorchiasis Treatment by Type - Medications Type and Surgery Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

China Historic Review for Opisthorchiasis Treatment by Type - Medications Type and Surgery Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR

China 16-Year Perspective for Opisthorchiasis Treatment by Type - Percentage Breakdown of Value Sales for Medications Type and Surgery Type for the Years 2014, 2025 & 2030

China Recent Past, Current & Future Analysis for Opisthorchiasis Treatment by Symptom - Fever Symptom, Splenomegaly Symptom, Weight loss Symptom, Tachycardia Symptom, Other Symptoms, Jaundice Symptom and Diarrhea Symptom - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

China Historic Review for Opisthorchiasis Treatment by Symptom - Fever Symptom, Splenomegaly Symptom, Weight loss Symptom, Tachycardia Symptom, Other Symptoms, Jaundice Symptom and Diarrhea Symptom Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR

China 16-Year Perspective for Opisthorchiasis Treatment by Symptom - Percentage Breakdown of Value Sales for Fever Symptom, Splenomegaly Symptom, Weight loss Symptom, Tachycardia Symptom, Other Symptoms, Jaundice Symptom and Diarrhea Symptom for the Years 2014, 2025 & 2030

China Recent Past, Current & Future Analysis for Opisthorchiasis Treatment by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

China Historic Review for Opisthorchiasis Treatment by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR

China 16-Year Perspective for Opisthorchiasis Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030

China Recent Past, Current & Future Analysis for Opisthorchiasis Treatment by Diagnostic Procedure - Cholangiography Diagnostic Procedure, MRI Diagnostic Procedure, Ultrasonography Diagnostic Procedure, CT scan Diagnostic Procedure and Other Diagnostic Procedures - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

China Historic Review for Opisthorchiasis Treatment by Diagnostic Procedure - Cholangiography Diagnostic Procedure, MRI Diagnostic Procedure, Ultrasonography Diagnostic Procedure, CT scan Diagnostic Procedure and Other Diagnostic Procedures Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR

China 16-Year Perspective for Opisthorchiasis Treatment by Diagnostic Procedure - Percentage Breakdown of Value Sales for Cholangiography Diagnostic Procedure, MRI Diagnostic Procedure, Ultrasonography Diagnostic Procedure, CT scan Diagnostic Procedure and Other Diagnostic Procedures for the Years 2014, 2025 & 2030

EUROPE

Opisthorchiasis Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)

Europe Recent Past, Current & Future Analysis for Opisthorchiasis Treatment by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR

Europe Historic Review for Opisthorchiasis Treatment by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR

Europe 16-Year Perspective for Opisthorchiasis Treatment by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2025 & 2030

Europe Recent Past, Current & Future Analysis for Opisthorchiasis Treatment by Type - Medications Type and Surgery Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Europe Historic Review for Opisthorchiasis Treatment by Type - Medications Type and Surgery Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR

Europe 16-Year Perspective for Opisthorchiasis Treatment by Type - Percentage Breakdown of Value Sales for Medications Type and Surgery Type for the Years 2014, 2025 & 2030

Europe Recent Past, Current & Future Analysis for Opisthorchiasis Treatment by Symptom - Fever Symptom, Splenomegaly Symptom, Weight loss Symptom, Tachycardia Symptom, Other Symptoms, Jaundice Symptom and Diarrhea Symptom - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Europe Historic Review for Opisthorchiasis Treatment by Symptom - Fever Symptom, Splenomegaly Symptom, Weight loss Symptom, Tachycardia Symptom, Other Symptoms, Jaundice Symptom and Diarrhea Symptom Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR

Europe 16-Year Perspective for Opisthorchiasis Treatment by Symptom - Percentage Breakdown of Value Sales for Fever Symptom, Splenomegaly Symptom, Weight loss Symptom, Tachycardia Symptom, Other Symptoms, Jaundice Symptom and Diarrhea Symptom for the Years 2014, 2025 & 2030

Europe Recent Past, Current & Future Analysis for Opisthorchiasis Treatment by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Europe Historic Review for Opisthorchiasis Treatment by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR

Europe 16-Year Perspective for Opisthorchiasis Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030

Europe Recent Past, Current & Future Analysis for Opisthorchiasis Treatment by Diagnostic Procedure - Cholangiography Diagnostic Procedure, MRI Diagnostic Procedure, Ultrasonography Diagnostic Procedure, CT scan Diagnostic Procedure and Other Diagnostic Procedures - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Europe Historic Review for Opisthorchiasis Treatment by Diagnostic Procedure - Cholangiography Diagnostic Procedure, MRI Diagnostic Procedure, Ultrasonography Diagnostic Procedure, CT scan Diagnostic Procedure and Other Diagnostic Procedures Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR

Europe 16-Year Perspective for Opisthorchiasis Treatment by Diagnostic Procedure - Percentage Breakdown of Value Sales for Cholangiography Diagnostic Procedure, MRI Diagnostic Procedure, Ultrasonography Diagnostic Procedure, CT scan Diagnostic Procedure and Other Diagnostic Procedures for the Years 2014, 2025 & 2030

FRANCE

Opisthorchiasis Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)

France Recent Past, Current & Future Analysis for Opisthorchiasis Treatment by Type - Medications Type and Surgery Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

France Historic Review for Opisthorchiasis Treatment by Type - Medications Type and Surgery Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR

France 16-Year Perspective for Opisthorchiasis Treatment by Type - Percentage Breakdown of Value Sales for Medications Type and Surgery Type for the Years 2014, 2025 & 2030

France Recent Past, Current & Future Analysis for Opisthorchiasis Treatment by Symptom - Fever Symptom, Splenomegaly Symptom, Weight loss Symptom, Tachycardia Symptom, Other Symptoms, Jaundice Symptom and Diarrhea Symptom - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

France Historic Review for Opisthorchiasis Treatment by Symptom - Fever Symptom, Splenomegaly Symptom, Weight loss Symptom, Tachycardia Symptom, Other Symptoms, Jaundice Symptom and Diarrhea Symptom Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR

France 16-Year Perspective for Opisthorchiasis Treatment by Symptom - Percentage Breakdown of Value Sales for Fever Symptom, Splenomegaly Symptom, Weight loss Symptom, Tachycardia Symptom, Other Symptoms, Jaundice Symptom and Diarrhea Symptom for the Years 2014, 2025 & 2030

France Recent Past, Current & Future Analysis for Opisthorchiasis Treatment by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

France Historic Review for Opisthorchiasis Treatment by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR

France 16-Year Perspective for Opisthorchiasis Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030

France Recent Past, Current & Future Analysis for Opisthorchiasis Treatment by Diagnostic Procedure - Cholangiography Diagnostic Procedure, MRI Diagnostic Procedure, Ultrasonography Diagnostic Procedure, CT scan Diagnostic Procedure and Other Diagnostic Procedures - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

France Historic Review for Opisthorchiasis Treatment by Diagnostic Procedure - Cholangiography Diagnostic Procedure, MRI Diagnostic Procedure, Ultrasonography Diagnostic Procedure, CT scan Diagnostic Procedure and Other Diagnostic Procedures Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR

France 16-Year Perspective for Opisthorchiasis Treatment by Diagnostic Procedure - Percentage Breakdown of Value Sales for Cholangiography Diagnostic Procedure, MRI Diagnostic Procedure, Ultrasonography Diagnostic Procedure, CT scan Diagnostic Procedure and Other Diagnostic Procedures for the Years 2014, 2025 & 2030

GERMANY

Opisthorchiasis Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)

Germany Recent Past, Current & Future Analysis for Opisthorchiasis Treatment by Type - Medications Type and Surgery Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Germany Historic Review for Opisthorchiasis Treatment by Type - Medications Type and Surgery Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR

Germany 16-Year Perspective for Opisthorchiasis Treatment by Type - Percentage Breakdown of Value Sales for Medications Type and Surgery Type for the Years 2014, 2025 & 2030

Germany Recent Past, Current & Future Analysis for Opisthorchiasis Treatment by Symptom - Fever Symptom, Splenomegaly Symptom, Weight loss Symptom, Tachycardia Symptom, Other Symptoms, Jaundice Symptom and Diarrhea Symptom - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Germany Historic Review for Opisthorchiasis Treatment by Symptom - Fever Symptom, Splenomegaly Symptom, Weight loss Symptom, Tachycardia Symptom, Other Symptoms, Jaundice Symptom and Diarrhea Symptom Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR

Germany 16-Year Perspective for Opisthorchiasis Treatment by Symptom - Percentage Breakdown of Value Sales for Fever Symptom, Splenomegaly Symptom, Weight loss Symptom, Tachycardia Symptom, Other Symptoms, Jaundice Symptom and Diarrhea Symptom for the Years 2014, 2025 & 2030

Germany Recent Past, Current & Future Analysis for Opisthorchiasis Treatment by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Germany Historic Review for Opisthorchiasis Treatment by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR

Germany 16-Year Perspective for Opisthorchiasis Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030

Germany Recent Past, Current & Future Analysis for Opisthorchiasis Treatment by Diagnostic Procedure - Cholangiography Diagnostic Procedure, MRI Diagnostic Procedure, Ultrasonography Diagnostic Procedure, CT scan Diagnostic Procedure and Other Diagnostic Procedures - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Germany Historic Review for Opisthorchiasis Treatment by Diagnostic Procedure - Cholangiography Diagnostic Procedure, MRI Diagnostic Procedure, Ultrasonography Diagnostic Procedure, CT scan Diagnostic Procedure and Other Diagnostic Procedures Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR

Germany 16-Year Perspective for Opisthorchiasis Treatment by Diagnostic Procedure - Percentage Breakdown of Value Sales for Cholangiography Diagnostic Procedure, MRI Diagnostic Procedure, Ultrasonography Diagnostic Procedure, CT scan Diagnostic Procedure and Other Diagnostic Procedures for the Years 2014, 2025 & 2030

ITALY

Italy Recent Past, Current & Future Analysis for Opisthorchiasis Treatment by Type - Medications Type and Surgery Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Italy Historic Review for Opisthorchiasis Treatment by Type - Medications Type and Surgery Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR

Italy 16-Year Perspective for Opisthorchiasis Treatment by Type - Percentage Breakdown of Value Sales for Medications Type and Surgery Type for the Years 2014, 2025 & 2030

Italy Recent Past, Current & Future Analysis for Opisthorchiasis Treatment by Symptom - Fever Symptom, Splenomegaly Symptom, Weight loss Symptom, Tachycardia Symptom, Other Symptoms, Jaundice Symptom and Diarrhea Symptom - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Italy Historic Review for Opisthorchiasis Treatment by Symptom - Fever Symptom, Splenomegaly Symptom, Weight loss Symptom, Tachycardia Symptom, Other Symptoms, Jaundice Symptom and Diarrhea Symptom Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR

Italy 16-Year Perspective for Opisthorchiasis Treatment by Symptom - Percentage Breakdown of Value Sales for Fever Symptom, Splenomegaly Symptom, Weight loss Symptom, Tachycardia Symptom, Other Symptoms, Jaundice Symptom and Diarrhea Symptom for the Years 2014, 2025 & 2030

Italy Recent Past, Current & Future Analysis for Opisthorchiasis Treatment by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Italy Historic Review for Opisthorchiasis Treatment by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR

Italy 16-Year Perspective for Opisthorchiasis Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030

Italy Recent Past, Current & Future Analysis for Opisthorchiasis Treatment by Diagnostic Procedure - Cholangiography Diagnostic Procedure, MRI Diagnostic Procedure, Ultrasonography Diagnostic Procedure, CT scan Diagnostic Procedure and Other Diagnostic Procedures - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Italy Historic Review for Opisthorchiasis Treatment by Diagnostic Procedure - Cholangiography Diagnostic Procedure, MRI Diagnostic Procedure, Ultrasonography Diagnostic Procedure, CT scan Diagnostic Procedure and Other Diagnostic Procedures Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR

Italy 16-Year Perspective for Opisthorchiasis Treatment by Diagnostic Procedure - Percentage Breakdown of Value Sales for Cholangiography Diagnostic Procedure, MRI Diagnostic Procedure, Ultrasonography Diagnostic Procedure, CT scan Diagnostic Procedure and Other Diagnostic Procedures for the Years 2014, 2025 & 2030

UNITED KINGDOM

Opisthorchiasis Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)

UK Recent Past, Current & Future Analysis for Opisthorchiasis Treatment by Type - Medications Type and Surgery Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

UK Historic Review for Opisthorchiasis Treatment by Type - Medications Type and Surgery Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR

UK 16-Year Perspective for Opisthorchiasis Treatment by Type - Percentage Breakdown of Value Sales for Medications Type and Surgery Type for the Years 2014, 2025 & 2030

UK Recent Past, Current & Future Analysis for Opisthorchiasis Treatment by Symptom - Fever Symptom, Splenomegaly Symptom, Weight loss Symptom, Tachycardia Symptom, Other Symptoms, Jaundice Symptom and Diarrhea Symptom - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

UK Historic Review for Opisthorchiasis Treatment by Symptom - Fever Symptom, Splenomegaly Symptom, Weight loss Symptom, Tachycardia Symptom, Other Symptoms, Jaundice Symptom and Diarrhea Symptom Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR

UK 16-Year Perspective for Opisthorchiasis Treatment by Symptom - Percentage Breakdown of Value Sales for Fever Symptom, Splenomegaly Symptom, Weight loss Symptom, Tachycardia Symptom, Other Symptoms, Jaundice Symptom and Diarrhea Symptom for the Years 2014, 2025 & 2030

UK Recent Past, Current & Future Analysis for Opisthorchiasis Treatment by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

UK Historic Review for Opisthorchiasis Treatment by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR

UK 16-Year Perspective for Opisthorchiasis Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030

UK Recent Past, Current & Future Analysis for Opisthorchiasis Treatment by Diagnostic Procedure - Cholangiography Diagnostic Procedure, MRI Diagnostic Procedure, Ultrasonography Diagnostic Procedure, CT scan Diagnostic Procedure and Other Diagnostic Procedures - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

UK Historic Review for Opisthorchiasis Treatment by Diagnostic Procedure - Cholangiography Diagnostic Procedure, MRI Diagnostic Procedure, Ultrasonography Diagnostic Procedure, CT scan Diagnostic Procedure and Other Diagnostic Procedures Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR

UK 16-Year Perspective for Opisthorchiasis Treatment by Diagnostic Procedure - Percentage Breakdown of Value Sales for Cholangiography Diagnostic Procedure, MRI Diagnostic Procedure, Ultrasonography Diagnostic Procedure, CT scan Diagnostic Procedure and Other Diagnostic Procedures for the Years 2014, 2025 & 2030

SPAIN

Spain Recent Past, Current & Future Analysis for Opisthorchiasis Treatment by Type - Medications Type and Surgery Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Spain Historic Review for Opisthorchiasis Treatment by Type - Medications Type and Surgery Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR

Spain 16-Year Perspective for Opisthorchiasis Treatment by Type - Percentage Breakdown of Value Sales for Medications Type and Surgery Type for the Years 2014, 2025 & 2030

Spain Recent Past, Current & Future Analysis for Opisthorchiasis Treatment by Symptom - Fever Symptom, Splenomegaly Symptom, Weight loss Symptom, Tachycardia Symptom, Other Symptoms, Jaundice Symptom and Diarrhea Symptom - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Spain Historic Review for Opisthorchiasis Treatment by Symptom - Fever Symptom, Splenomegaly Symptom, Weight loss Symptom, Tachycardia Symptom, Other Symptoms, Jaundice Symptom and Diarrhea Symptom Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR

Spain 16-Year Perspective for Opisthorchiasis Treatment by Symptom - Percentage Breakdown of Value Sales for Fever Symptom, Splenomegaly Symptom, Weight loss Symptom, Tachycardia Symptom, Other Symptoms, Jaundice Symptom and Diarrhea Symptom for the Years 2014, 2025 & 2030

Spain Recent Past, Current & Future Analysis for Opisthorchiasis Treatment by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Spain Historic Review for Opisthorchiasis Treatment by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR

Spain 16-Year Perspective for Opisthorchiasis Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030

Spain Recent Past, Current & Future Analysis for Opisthorchiasis Treatment by Diagnostic Procedure - Cholangiography Diagnostic Procedure, MRI Diagnostic Procedure, Ultrasonography Diagnostic Procedure, CT scan Diagnostic Procedure and Other Diagnostic Procedures - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Spain Historic Review for Opisthorchiasis Treatment by Diagnostic Procedure - Cholangiography Diagnostic Procedure, MRI Diagnostic Procedure, Ultrasonography Diagnostic Procedure, CT scan Diagnostic Procedure and Other Diagnostic Procedures Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR

Spain 16-Year Perspective for Opisthorchiasis Treatment by Diagnostic Procedure - Percentage Breakdown of Value Sales for Cholangiography Diagnostic Procedure, MRI Diagnostic Procedure, Ultrasonography Diagnostic Procedure, CT scan Diagnostic Procedure and Other Diagnostic Procedures for the Years 2014, 2025 & 2030

RUSSIA

Russia Recent Past, Current & Future Analysis for Opisthorchiasis Treatment by Type - Medications Type and Surgery Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Russia Historic Review for Opisthorchiasis Treatment by Type - Medications Type and Surgery Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR

Russia 16-Year Perspective for Opisthorchiasis Treatment by Type - Percentage Breakdown of Value Sales for Medications Type and Surgery Type for the Years 2014, 2025 & 2030

Russia Recent Past, Current & Future Analysis for Opisthorchiasis Treatment by Symptom - Fever Symptom, Splenomegaly Symptom, Weight loss Symptom, Tachycardia Symptom, Other Symptoms, Jaundice Symptom and Diarrhea Symptom - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Russia Historic Review for Opisthorchiasis Treatment by Symptom - Fever Symptom, Splenomegaly Symptom, Weight loss Symptom, Tachycardia Symptom, Other Symptoms, Jaundice Symptom and Diarrhea Symptom Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR

Russia 16-Year Perspective for Opisthorchiasis Treatment by Symptom - Percentage Breakdown of Value Sales for Fever Symptom, Splenomegaly Symptom, Weight loss Symptom, Tachycardia Symptom, Other Symptoms, Jaundice Symptom and Diarrhea Symptom for the Years 2014, 2025 & 2030

Russia Recent Past, Current & Future Analysis for Opisthorchiasis Treatment by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Russia Historic Review for Opisthorchiasis Treatment by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR

Russia 16-Year Perspective for Opisthorchiasis Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030

Russia Recent Past, Current & Future Analysis for Opisthorchiasis Treatment by Diagnostic Procedure - Cholangiography Diagnostic Procedure, MRI Diagnostic Procedure, Ultrasonography Diagnostic Procedure, CT scan Diagnostic Procedure and Other Diagnostic Procedures - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Russia Historic Review for Opisthorchiasis Treatment by Diagnostic Procedure - Cholangiography Diagnostic Procedure, MRI Diagnostic Procedure, Ultrasonography Diagnostic Procedure, CT scan Diagnostic Procedure and Other Diagnostic Procedures Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR

Russia 16-Year Perspective for Opisthorchiasis Treatment by Diagnostic Procedure - Percentage Breakdown of Value Sales for Cholangiography Diagnostic Procedure, MRI Diagnostic Procedure, Ultrasonography Diagnostic Procedure, CT scan Diagnostic Procedure and Other Diagnostic Procedures for the Years 2014, 2025 & 2030

REST OF EUROPE

Rest of Europe Recent Past, Current & Future Analysis for Opisthorchiasis Treatment by Type - Medications Type and Surgery Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Rest of Europe Historic Review for Opisthorchiasis Treatment by Type - Medications Type and Surgery Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR

Rest of Europe 16-Year Perspective for Opisthorchiasis Treatment by Type - Percentage Breakdown of Value Sales for Medications Type and Surgery Type for the Years 2014, 2025 & 2030

Rest of Europe Recent Past, Current & Future Analysis for Opisthorchiasis Treatment by Symptom - Fever Symptom, Splenomegaly Symptom, Weight loss Symptom, Tachycardia Symptom, Other Symptoms, Jaundice Symptom and Diarrhea Symptom - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Rest of Europe Historic Review for Opisthorchiasis Treatment by Symptom - Fever Symptom, Splenomegaly Symptom, Weight loss Symptom, Tachycardia Symptom, Other Symptoms, Jaundice Symptom and Diarrhea Symptom Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR

Rest of Europe 16-Year Perspective for Opisthorchiasis Treatment by Symptom - Percentage Breakdown of Value Sales for Fever Symptom, Splenomegaly Symptom, Weight loss Symptom, Tachycardia Symptom, Other Symptoms, Jaundice Symptom and Diarrhea Symptom for the Years 2014, 2025 & 2030

Rest of Europe Recent Past, Current & Future Analysis for Opisthorchiasis Treatment by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Rest of Europe Historic Review for Opisthorchiasis Treatment by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR

Rest of Europe 16-Year Perspective for Opisthorchiasis Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030

Rest of Europe Recent Past, Current & Future Analysis for Opisthorchiasis Treatment by Diagnostic Procedure - Cholangiography Diagnostic Procedure, MRI Diagnostic Procedure, Ultrasonography Diagnostic Procedure, CT scan Diagnostic Procedure and Other Diagnostic Procedures - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Rest of Europe Historic Review for Opisthorchiasis Treatment by Diagnostic Procedure - Cholangiography Diagnostic Procedure, MRI Diagnostic Procedure, Ultrasonography Diagnostic Procedure, CT scan Diagnostic Procedure and Other Diagnostic Procedures Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR

Rest of Europe 16-Year Perspective for Opisthorchiasis Treatment by Diagnostic Procedure - Percentage Breakdown of Value Sales for Cholangiography Diagnostic Procedure, MRI Diagnostic Procedure, Ultrasonography Diagnostic Procedure, CT scan Diagnostic Procedure and Other Diagnostic Procedures for the Years 2014, 2025 & 2030

ASIA-PACIFIC

Opisthorchiasis Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)

Asia-Pacific Recent Past, Current & Future Analysis for Opisthorchiasis Treatment by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR

Asia-Pacific Historic Review for Opisthorchiasis Treatment by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR

Asia-Pacific 16-Year Perspective for Opisthorchiasis Treatment by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2025 & 2030

Asia-Pacific Recent Past, Current & Future Analysis for Opisthorchiasis Treatment by Type - Medications Type and Surgery Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Asia-Pacific Historic Review for Opisthorchiasis Treatment by Type - Medications Type and Surgery Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR

Asia-Pacific 16-Year Perspective for Opisthorchiasis Treatment by Type - Percentage Breakdown of Value Sales for Medications Type and Surgery Type for the Years 2014, 2025 & 2030

Asia-Pacific Recent Past, Current & Future Analysis for Opisthorchiasis Treatment by Symptom - Fever Symptom, Splenomegaly Symptom, Weight loss Symptom, Tachycardia Symptom, Other Symptoms, Jaundice Symptom and Diarrhea Symptom - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Asia-Pacific Historic Review for Opisthorchiasis Treatment by Symptom - Fever Symptom, Splenomegaly Symptom, Weight loss Symptom, Tachycardia Symptom, Other Symptoms, Jaundice Symptom and Diarrhea Symptom Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR

Asia-Pacific 16-Year Perspective for Opisthorchiasis Treatment by Symptom - Percentage Breakdown of Value Sales for Fever Symptom, Splenomegaly Symptom, Weight loss Symptom, Tachycardia Symptom, Other Symptoms, Jaundice Symptom and Diarrhea Symptom for the Years 2014, 2025 & 2030

Asia-Pacific Recent Past, Current & Future Analysis for Opisthorchiasis Treatment by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Asia-Pacific Historic Review for Opisthorchiasis Treatment by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR

Asia-Pacific 16-Year Perspective for Opisthorchiasis Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030

Asia-Pacific Recent Past, Current & Future Analysis for Opisthorchiasis Treatment by Diagnostic Procedure - Cholangiography Diagnostic Procedure, MRI Diagnostic Procedure, Ultrasonography Diagnostic Procedure, CT scan Diagnostic Procedure and Other Diagnostic Procedures - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Asia-Pacific Historic Review for Opisthorchiasis Treatment by Diagnostic Procedure - Cholangiography Diagnostic Procedure, MRI Diagnostic Procedure, Ultrasonography Diagnostic Procedure, CT scan Diagnostic Procedure and Other Diagnostic Procedures Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR

Asia-Pacific 16-Year Perspective for Opisthorchiasis Treatment by Diagnostic Procedure - Percentage Breakdown of Value Sales for Cholangiography Diagnostic Procedure, MRI Diagnostic Procedure, Ultrasonography Diagnostic Procedure, CT scan Diagnostic Procedure and Other Diagnostic Procedures for the Years 2014, 2025 & 2030

AUSTRALIA

Opisthorchiasis Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)

Australia Recent Past, Current & Future Analysis for Opisthorchiasis Treatment by Type - Medications Type and Surgery Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Australia Historic Review for Opisthorchiasis Treatment by Type - Medications Type and Surgery Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR

Australia 16-Year Perspective for Opisthorchiasis Treatment by Type - Percentage Breakdown of Value Sales for Medications Type and Surgery Type for the Years 2014, 2025 & 2030

Australia Recent Past, Current & Future Analysis for Opisthorchiasis Treatment by Symptom - Fever Symptom, Splenomegaly Symptom, Weight loss Symptom, Tachycardia Symptom, Other Symptoms, Jaundice Symptom and Diarrhea Symptom - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Australia Historic Review for Opisthorchiasis Treatment by Symptom - Fever Symptom, Splenomegaly Symptom, Weight loss Symptom, Tachycardia Symptom, Other Symptoms, Jaundice Symptom and Diarrhea Symptom Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR

Australia 16-Year Perspective for Opisthorchiasis Treatment by Symptom - Percentage Breakdown of Value Sales for Fever Symptom, Splenomegaly Symptom, Weight loss Symptom, Tachycardia Symptom, Other Symptoms, Jaundice Symptom and Diarrhea Symptom for the Years 2014, 2025 & 2030

Australia Recent Past, Current & Future Analysis for Opisthorchiasis Treatment by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Australia Historic Review for Opisthorchiasis Treatment by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR

Australia 16-Year Perspective for Opisthorchiasis Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030

Australia Recent Past, Current & Future Analysis for Opisthorchiasis Treatment by Diagnostic Procedure - Cholangiography Diagnostic Procedure, MRI Diagnostic Procedure, Ultrasonography Diagnostic Procedure, CT scan Diagnostic Procedure and Other Diagnostic Procedures - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Australia Historic Review for Opisthorchiasis Treatment by Diagnostic Procedure - Cholangiography Diagnostic Procedure, MRI Diagnostic Procedure, Ultrasonography Diagnostic Procedure, CT scan Diagnostic Procedure and Other Diagnostic Procedures Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR

Australia 16-Year Perspective for Opisthorchiasis Treatment by Diagnostic Procedure - Percentage Breakdown of Value Sales for Cholangiography Diagnostic Procedure, MRI Diagnostic Procedure, Ultrasonography Diagnostic Procedure, CT scan Diagnostic Procedure and Other Diagnostic Procedures for the Years 2014, 2025 & 2030

INDIA

Opisthorchiasis Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)

India Recent Past, Current & Future Analysis for Opisthorchiasis Treatment by Type - Medications Type and Surgery Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

India Historic Review for Opisthorchiasis Treatment by Type - Medications Type and Surgery Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR

India 16-Year Perspective for Opisthorchiasis Treatment by Type - Percentage Breakdown of Value Sales for Medications Type and Surgery Type for the Years 2014, 2025 & 2030

India Recent Past, Current & Future Analysis for Opisthorchiasis Treatment by Symptom - Fever Symptom, Splenomegaly Symptom, Weight loss Symptom, Tachycardia Symptom, Other Symptoms, Jaundice Symptom and Diarrhea Symptom - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

India Historic Review for Opisthorchiasis Treatment by Symptom - Fever Symptom, Splenomegaly Symptom, Weight loss Symptom, Tachycardia Symptom, Other Symptoms, Jaundice Symptom and Diarrhea Symptom Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR

India 16-Year Perspective for Opisthorchiasis Treatment by Symptom - Percentage Breakdown of Value Sales for Fever Symptom, Splenomegaly Symptom, Weight loss Symptom, Tachycardia Symptom, Other Symptoms, Jaundice Symptom and Diarrhea Symptom for the Years 2014, 2025 & 2030

India Recent Past, Current & Future Analysis for Opisthorchiasis Treatment by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

India Historic Review for Opisthorchiasis Treatment by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR

India 16-Year Perspective for Opisthorchiasis Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030

India Recent Past, Current & Future Analysis for Opisthorchiasis Treatment by Diagnostic Procedure - Cholangiography Diagnostic Procedure, MRI Diagnostic Procedure, Ultrasonography Diagnostic Procedure, CT scan Diagnostic Procedure and Other Diagnostic Procedures - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

India Historic Review for Opisthorchiasis Treatment by Diagnostic Procedure - Cholangiography Diagnostic Procedure, MRI Diagnostic Procedure, Ultrasonography Diagnostic Procedure, CT scan Diagnostic Procedure and Other Diagnostic Procedures Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR

India 16-Year Perspective for Opisthorchiasis Treatment by Diagnostic Procedure - Percentage Breakdown of Value Sales for Cholangiography Diagnostic Procedure, MRI Diagnostic Procedure, Ultrasonography Diagnostic Procedure, CT scan Diagnostic Procedure and Other Diagnostic Procedures for the Years 2014, 2025 & 2030

SOUTH KOREA

South Korea Recent Past, Current & Future Analysis for Opisthorchiasis Treatment by Type - Medications Type and Surgery Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

South Korea Historic Review for Opisthorchiasis Treatment by Type - Medications Type and Surgery Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR

South Korea 16-Year Perspective for Opisthorchiasis Treatment by Type - Percentage Breakdown of Value Sales for Medications Type and Surgery Type for the Years 2014, 2025 & 2030

South Korea Recent Past, Current & Future Analysis for Opisthorchiasis Treatment by Symptom - Fever Symptom, Splenomegaly Symptom, Weight loss Symptom, Tachycardia Symptom, Other Symptoms, Jaundice Symptom and Diarrhea Symptom - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

South Korea Historic Review for Opisthorchiasis Treatment by Symptom - Fever Symptom, Splenomegaly Symptom, Weight loss Symptom, Tachycardia Symptom, Other Symptoms, Jaundice Symptom and Diarrhea Symptom Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR

South Korea 16-Year Perspective for Opisthorchiasis Treatment by Symptom - Percentage Breakdown of Value Sales for Fever Symptom, Splenomegaly Symptom, Weight loss Symptom, Tachycardia Symptom, Other Symptoms, Jaundice Symptom and Diarrhea Symptom for the Years 2014, 2025 & 2030

South Korea Recent Past, Current & Future Analysis for Opisthorchiasis Treatment by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

South Korea Historic Review for Opisthorchiasis Treatment by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR

South Korea 16-Year Perspective for Opisthorchiasis Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030

South Korea Recent Past, Current & Future Analysis for Opisthorchiasis Treatment by Diagnostic Procedure - Cholangiography Diagnostic Procedure, MRI Diagnostic Procedure, Ultrasonography Diagnostic Procedure, CT scan Diagnostic Procedure and Other Diagnostic Procedures - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

South Korea Historic Review for Opisthorchiasis Treatment by Diagnostic Procedure - Cholangiography Diagnostic Procedure, MRI Diagnostic Procedure, Ultrasonography Diagnostic Procedure, CT scan Diagnostic Procedure and Other Diagnostic Procedures Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR

South Korea 16-Year Perspective for Opisthorchiasis Treatment by Diagnostic Procedure - Percentage Breakdown of Value Sales for Cholangiography Diagnostic Procedure, MRI Diagnostic Procedure, Ultrasonography Diagnostic Procedure, CT scan Diagnostic Procedure and Other Diagnostic Procedures for the Years 2014, 2025 & 2030

REST OF ASIA-PACIFIC

Rest of Asia-Pacific Recent Past, Current & Future Analysis for Opisthorchiasis Treatment by Type - Medications Type and Surgery Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Rest of Asia-Pacific Historic Review for Opisthorchiasis Treatment by Type - Medications Type and Surgery Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR

Rest of Asia-Pacific 16-Year Perspective for Opisthorchiasis Treatment by Type - Percentage Breakdown of Value Sales for Medications Type and Surgery Type for the Years 2014, 2025 & 2030

Rest of Asia-Pacific Recent Past, Current & Future Analysis for Opisthorchiasis Treatment by Symptom - Fever Symptom, Splenomegaly Symptom, Weight loss Symptom, Tachycardia Symptom, Other Symptoms, Jaundice Symptom and Diarrhea Symptom - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Rest of Asia-Pacific Historic Review for Opisthorchiasis Treatment by Symptom - Fever Symptom, Splenomegaly Symptom, Weight loss Symptom, Tachycardia Symptom, Other Symptoms, Jaundice Symptom and Diarrhea Symptom Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR

Rest of Asia-Pacific 16-Year Perspective for Opisthorchiasis Treatment by Symptom - Percentage Breakdown of Value Sales for Fever Symptom, Splenomegaly Symptom, Weight loss Symptom, Tachycardia Symptom, Other Symptoms, Jaundice Symptom and Diarrhea Symptom for the Years 2014, 2025 & 2030

Rest of Asia-Pacific Recent Past, Current & Future Analysis for Opisthorchiasis Treatment by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Rest of Asia-Pacific Historic Review for Opisthorchiasis Treatment by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR

Rest of Asia-Pacific 16-Year Perspective for Opisthorchiasis Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030

Rest of Asia-Pacific Recent Past, Current & Future Analysis for Opisthorchiasis Treatment by Diagnostic Procedure - Cholangiography Diagnostic Procedure, MRI Diagnostic Procedure, Ultrasonography Diagnostic Procedure, CT scan Diagnostic Procedure and Other Diagnostic Procedures - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Rest of Asia-Pacific Historic Review for Opisthorchiasis Treatment by Diagnostic Procedure - Cholangiography Diagnostic Procedure, MRI Diagnostic Procedure, Ultrasonography Diagnostic Procedure, CT scan Diagnostic Procedure and Other Diagnostic Procedures Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR

Rest of Asia-Pacific 16-Year Perspective for Opisthorchiasis Treatment by Diagnostic Procedure - Percentage Breakdown of Value Sales for Cholangiography Diagnostic Procedure, MRI Diagnostic Procedure, Ultrasonography Diagnostic Procedure, CT scan Diagnostic Procedure and Other Diagnostic Procedures for the Years 2014, 2025 & 2030

LATIN AMERICA

Opisthorchiasis Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)

Latin America Recent Past, Current & Future Analysis for Opisthorchiasis Treatment by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR

Latin America Historic Review for Opisthorchiasis Treatment by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR

Latin America 16-Year Perspective for Opisthorchiasis Treatment by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2025 & 2030

Latin America Recent Past, Current & Future Analysis for Opisthorchiasis Treatment by Type - Medications Type and Surgery Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Latin America Historic Review for Opisthorchiasis Treatment by Type - Medications Type and Surgery Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR

Latin America 16-Year Perspective for Opisthorchiasis Treatment by Type - Percentage Breakdown of Value Sales for Medications Type and Surgery Type for the Years 2014, 2025 & 2030

Latin America Recent Past, Current & Future Analysis for Opisthorchiasis Treatment by Symptom - Fever Symptom, Splenomegaly Symptom, Weight loss Symptom, Tachycardia Symptom, Other Symptoms, Jaundice Symptom and Diarrhea Symptom - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Latin America Historic Review for Opisthorchiasis Treatment by Symptom - Fever Symptom, Splenomegaly Symptom, Weight loss Symptom, Tachycardia Symptom, Other Symptoms, Jaundice Symptom and Diarrhea Symptom Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR

Latin America 16-Year Perspective for Opisthorchiasis Treatment by Symptom - Percentage Breakdown of Value Sales for Fever Symptom, Splenomegaly Symptom, Weight loss Symptom, Tachycardia Symptom, Other Symptoms, Jaundice Symptom and Diarrhea Symptom for the Years 2014, 2025 & 2030

Latin America Recent Past, Current & Future Analysis for Opisthorchiasis Treatment by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Latin America Historic Review for Opisthorchiasis Treatment by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR

Latin America 16-Year Perspective for Opisthorchiasis Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030

Latin America Recent Past, Current & Future Analysis for Opisthorchiasis Treatment by Diagnostic Procedure - Cholangiography Diagnostic Procedure, MRI Diagnostic Procedure, Ultrasonography Diagnostic Procedure, CT scan Diagnostic Procedure and Other Diagnostic Procedures - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Latin America Historic Review for Opisthorchiasis Treatment by Diagnostic Procedure - Cholangiography Diagnostic Procedure, MRI Diagnostic Procedure, Ultrasonography Diagnostic Procedure, CT scan Diagnostic Procedure and Other Diagnostic Procedures Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR

Latin America 16-Year Perspective for Opisthorchiasis Treatment by Diagnostic Procedure - Percentage Breakdown of Value Sales for Cholangiography Diagnostic Procedure, MRI Diagnostic Procedure, Ultrasonography Diagnostic Procedure, CT scan Diagnostic Procedure and Other Diagnostic Procedures for the Years 2014, 2025 & 2030

ARGENTINA

Argentina Recent Past, Current & Future Analysis for Opisthorchiasis Treatment by Type - Medications Type and Surgery Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Argentina Historic Review for Opisthorchiasis Treatment by Type - Medications Type and Surgery Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR

Argentina 16-Year Perspective for Opisthorchiasis Treatment by Type - Percentage Breakdown of Value Sales for Medications Type and Surgery Type for the Years 2014, 2025 & 2030

Argentina Recent Past, Current & Future Analysis for Opisthorchiasis Treatment by Symptom - Fever Symptom, Splenomegaly Symptom, Weight loss Symptom, Tachycardia Symptom, Other Symptoms, Jaundice Symptom and Diarrhea Symptom - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Argentina Historic Review for Opisthorchiasis Treatment by Symptom - Fever Symptom, Splenomegaly Symptom, Weight loss Symptom, Tachycardia Symptom, Other Symptoms, Jaundice Symptom and Diarrhea Symptom Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR

Argentina 16-Year Perspective for Opisthorchiasis Treatment by Symptom - Percentage Breakdown of Value Sales for Fever Symptom, Splenomegaly Symptom, Weight loss Symptom, Tachycardia Symptom, Other Symptoms, Jaundice Symptom and Diarrhea Symptom for the Years 2014, 2025 & 2030

Argentina Recent Past, Current & Future Analysis for Opisthorchiasis Treatment by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Argentina Historic Review for Opisthorchiasis Treatment by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR

Argentina 16-Year Perspective for Opisthorchiasis Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030

Argentina Recent Past, Current & Future Analysis for Opisthorchiasis Treatment by Diagnostic Procedure - Cholangiography Diagnostic Procedure, MRI Diagnostic Procedure, Ultrasonography Diagnostic Procedure, CT scan Diagnostic Procedure and Other Diagnostic Procedures - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Argentina Historic Review for Opisthorchiasis Treatment by Diagnostic Procedure - Cholangiography Diagnostic Procedure, MRI Diagnostic Procedure, Ultrasonography Diagnostic Procedure, CT scan Diagnostic Procedure and Other Diagnostic Procedures Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR

Argentina 16-Year Perspective for Opisthorchiasis Treatment by Diagnostic Procedure - Percentage Breakdown of Value Sales for Cholangiography Diagnostic Procedure, MRI Diagnostic Procedure, Ultrasonography Diagnostic Procedure, CT scan Diagnostic Procedure and Other Diagnostic Procedures for the Years 2014, 2025 & 2030

BRAZIL

Brazil Recent Past, Current & Future Analysis for Opisthorchiasis Treatment by Type - Medications Type and Surgery Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Brazil Historic Review for Opisthorchiasis Treatment by Type - Medications Type and Surgery Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR

Brazil 16-Year Perspective for Opisthorchiasis Treatment by Type - Percentage Breakdown of Value Sales for Medications Type and Surgery Type for the Years 2014, 2025 & 2030

Brazil Recent Past, Current & Future Analysis for Opisthorchiasis Treatment by Symptom - Fever Symptom, Splenomegaly Symptom, Weight loss Symptom, Tachycardia Symptom, Other Symptoms, Jaundice Symptom and Diarrhea Symptom - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Brazil Historic Review for Opisthorchiasis Treatment by Symptom - Fever Symptom, Splenomegaly Symptom, Weight loss Symptom, Tachycardia Symptom, Other Symptoms, Jaundice Symptom and Diarrhea Symptom Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR

Brazil 16-Year Perspective for Opisthorchiasis Treatment by Symptom - Percentage Breakdown of Value Sales for Fever Symptom, Splenomegaly Symptom, Weight loss Symptom, Tachycardia Symptom, Other Symptoms, Jaundice Symptom and Diarrhea Symptom for the Years 2014, 2025 & 2030

Brazil Recent Past, Current & Future Analysis for Opisthorchiasis Treatment by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Brazil Historic Review for Opisthorchiasis Treatment by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR

Brazil 16-Year Perspective for Opisthorchiasis Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030

Brazil Recent Past, Current & Future Analysis for Opisthorchiasis Treatment by Diagnostic Procedure - Cholangiography Diagnostic Procedure, MRI Diagnostic Procedure, Ultrasonography Diagnostic Procedure, CT scan Diagnostic Procedure and Other Diagnostic Procedures - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Brazil Historic Review for Opisthorchiasis Treatment by Diagnostic Procedure - Cholangiography Diagnostic Procedure, MRI Diagnostic Procedure, Ultrasonography Diagnostic Procedure, CT scan Diagnostic Procedure and Other Diagnostic Procedures Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR

Brazil 16-Year Perspective for Opisthorchiasis Treatment by Diagnostic Procedure - Percentage Breakdown of Value Sales for Cholangiography Diagnostic Procedure, MRI Diagnostic Procedure, Ultrasonography Diagnostic Procedure, CT scan Diagnostic Procedure and Other Diagnostic Procedures for the Years 2014, 2025 & 2030

MEXICO

Mexico Recent Past, Current & Future Analysis for Opisthorchiasis Treatment by Type - Medications Type and Surgery Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Mexico Historic Review for Opisthorchiasis Treatment by Type - Medications Type and Surgery Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR

Mexico 16-Year Perspective for Opisthorchiasis Treatment by Type - Percentage Breakdown of Value Sales for Medications Type and Surgery Type for the Years 2014, 2025 & 2030

Mexico Recent Past, Current & Future Analysis for Opisthorchiasis Treatment by Symptom - Fever Symptom, Splenomegaly Symptom, Weight loss Symptom, Tachycardia Symptom, Other Symptoms, Jaundice Symptom and Diarrhea Symptom - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Mexico Historic Review for Opisthorchiasis Treatment by Symptom - Fever Symptom, Splenomegaly Symptom, Weight loss Symptom, Tachycardia Symptom, Other Symptoms, Jaundice Symptom and Diarrhea Symptom Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR

Mexico 16-Year Perspective for Opisthorchiasis Treatment by Symptom - Percentage Breakdown of Value Sales for Fever Symptom, Splenomegaly Symptom, Weight loss Symptom, Tachycardia Symptom, Other Symptoms, Jaundice Symptom and Diarrhea Symptom for the Years 2014, 2025 & 2030

Mexico Recent Past, Current & Future Analysis for Opisthorchiasis Treatment by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Mexico Historic Review for Opisthorchiasis Treatment by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR

Mexico 16-Year Perspective for Opisthorchiasis Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030

Mexico Recent Past, Current & Future Analysis for Opisthorchiasis Treatment by Diagnostic Procedure - Cholangiography Diagnostic Procedure, MRI Diagnostic Procedure, Ultrasonography Diagnostic Procedure, CT scan Diagnostic Procedure and Other Diagnostic Procedures - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Mexico Historic Review for Opisthorchiasis Treatment by Diagnostic Procedure - Cholangiography Diagnostic Procedure, MRI Diagnostic Procedure, Ultrasonography Diagnostic Procedure, CT scan Diagnostic Procedure and Other Diagnostic Procedures Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR

Mexico 16-Year Perspective for Opisthorchiasis Treatment by Diagnostic Procedure - Percentage Breakdown of Value Sales for Cholangiography Diagnostic Procedure, MRI Diagnostic Procedure, Ultrasonography Diagnostic Procedure, CT scan Diagnostic Procedure and Other Diagnostic Procedures for the Years 2014, 2025 & 2030

REST OF LATIN AMERICA

Rest of Latin America Recent Past, Current & Future Analysis for Opisthorchiasis Treatment by Type - Medications Type and Surgery Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Rest of Latin America Historic Review for Opisthorchiasis Treatment by Type - Medications Type and Surgery Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR

Rest of Latin America 16-Year Perspective for Opisthorchiasis Treatment by Type - Percentage Breakdown of Value Sales for Medications Type and Surgery Type for the Years 2014, 2025 & 2030

Rest of Latin America Recent Past, Current & Future Analysis for Opisthorchiasis Treatment by Symptom - Fever Symptom, Splenomegaly Symptom, Weight loss Symptom, Tachycardia Symptom, Other Symptoms, Jaundice Symptom and Diarrhea Symptom - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Rest of Latin America Historic Review for Opisthorchiasis Treatment by Symptom - Fever Symptom, Splenomegaly Symptom, Weight loss Symptom, Tachycardia Symptom, Other Symptoms, Jaundice Symptom and Diarrhea Symptom Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR

Rest of Latin America 16-Year Perspective for Opisthorchiasis Treatment by Symptom - Percentage Breakdown of Value Sales for Fever Symptom, Splenomegaly Symptom, Weight loss Symptom, Tachycardia Symptom, Other Symptoms, Jaundice Symptom and Diarrhea Symptom for the Years 2014, 2025 & 2030

Rest of Latin America Recent Past, Current & Future Analysis for Opisthorchiasis Treatment by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Rest of Latin America Historic Review for Opisthorchiasis Treatment by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR

Rest of Latin America 16-Year Perspective for Opisthorchiasis Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030

Rest of Latin America Recent Past, Current & Future Analysis for Opisthorchiasis Treatment by Diagnostic Procedure - Cholangiography Diagnostic Procedure, MRI Diagnostic Procedure, Ultrasonography Diagnostic Procedure, CT scan Diagnostic Procedure and Other Diagnostic Procedures - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Rest of Latin America Historic Review for Opisthorchiasis Treatment by Diagnostic Procedure - Cholangiography Diagnostic Procedure, MRI Diagnostic Procedure, Ultrasonography Diagnostic Procedure, CT scan Diagnostic Procedure and Other Diagnostic Procedures Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR

Rest of Latin America 16-Year Perspective for Opisthorchiasis Treatment by Diagnostic Procedure - Percentage Breakdown of Value Sales for Cholangiography Diagnostic Procedure, MRI Diagnostic Procedure, Ultrasonography Diagnostic Procedure, CT scan Diagnostic Procedure and Other Diagnostic Procedures for the Years 2014, 2025 & 2030

MIDDLE EAST

Opisthorchiasis Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)

Middle East Recent Past, Current & Future Analysis for Opisthorchiasis Treatment by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR

Middle East Historic Review for Opisthorchiasis Treatment by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR

Middle East 16-Year Perspective for Opisthorchiasis Treatment by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2025 & 2030

Middle East Recent Past, Current & Future Analysis for Opisthorchiasis Treatment by Type - Medications Type and Surgery Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Middle East Historic Review for Opisthorchiasis Treatment by Type - Medications Type and Surgery Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR

Middle East 16-Year Perspective for Opisthorchiasis Treatment by Type - Percentage Breakdown of Value Sales for Medications Type and Surgery Type for the Years 2014, 2025 & 2030

Middle East Recent Past, Current & Future Analysis for Opisthorchiasis Treatment by Symptom - Fever Symptom, Splenomegaly Symptom, Weight loss Symptom, Tachycardia Symptom, Other Symptoms, Jaundice Symptom and Diarrhea Symptom - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Middle East Historic Review for Opisthorchiasis Treatment by Symptom - Fever Symptom, Splenomegaly Symptom, Weight loss Symptom, Tachycardia Symptom, Other Symptoms, Jaundice Symptom and Diarrhea Symptom Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR

Middle East 16-Year Perspective for Opisthorchiasis Treatment by Symptom - Percentage Breakdown of Value Sales for Fever Symptom, Splenomegaly Symptom, Weight loss Symptom, Tachycardia Symptom, Other Symptoms, Jaundice Symptom and Diarrhea Symptom for the Years 2014, 2025 & 2030

Middle East Recent Past, Current & Future Analysis for Opisthorchiasis Treatment by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Middle East Historic Review for Opisthorchiasis Treatment by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR

Middle East 16-Year Perspective for Opisthorchiasis Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030

Middle East Recent Past, Current & Future Analysis for Opisthorchiasis Treatment by Diagnostic Procedure - Cholangiography Diagnostic Procedure, MRI Diagnostic Procedure, Ultrasonography Diagnostic Procedure, CT scan Diagnostic Procedure and Other Diagnostic Procedures - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Middle East Historic Review for Opisthorchiasis Treatment by Diagnostic Procedure - Cholangiography Diagnostic Procedure, MRI Diagnostic Procedure, Ultrasonography Diagnostic Procedure, CT scan Diagnostic Procedure and Other Diagnostic Procedures Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR

Middle East 16-Year Perspective for Opisthorchiasis Treatment by Diagnostic Procedure - Percentage Breakdown of Value Sales for Cholangiography Diagnostic Procedure, MRI Diagnostic Procedure, Ultrasonography Diagnostic Procedure, CT scan Diagnostic Procedure and Other Diagnostic Procedures for the Years 2014, 2025 & 2030

IRAN

Iran Recent Past, Current & Future Analysis for Opisthorchiasis Treatment by Type - Medications Type and Surgery Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Iran Historic Review for Opisthorchiasis Treatment by Type - Medications Type and Surgery Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR

Iran 16-Year Perspective for Opisthorchiasis Treatment by Type - Percentage Breakdown of Value Sales for Medications Type and Surgery Type for the Years 2014, 2025 & 2030

Iran Recent Past, Current & Future Analysis for Opisthorchiasis Treatment by Symptom - Fever Symptom, Splenomegaly Symptom, Weight loss Symptom, Tachycardia Symptom, Other Symptoms, Jaundice Symptom and Diarrhea Symptom - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Iran Historic Review for Opisthorchiasis Treatment by Symptom - Fever Symptom, Splenomegaly Symptom, Weight loss Symptom, Tachycardia Symptom, Other Symptoms, Jaundice Symptom and Diarrhea Symptom Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR

Iran 16-Year Perspective for Opisthorchiasis Treatment by Symptom - Percentage Breakdown of Value Sales for Fever Symptom, Splenomegaly Symptom, Weight loss Symptom, Tachycardia Symptom, Other Symptoms, Jaundice Symptom and Diarrhea Symptom for the Years 2014, 2025 & 2030

Iran Recent Past, Current & Future Analysis for Opisthorchiasis Treatment by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Iran Historic Review for Opisthorchiasis Treatment by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR

Iran 16-Year Perspective for Opisthorchiasis Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030

Iran Recent Past, Current & Future Analysis for Opisthorchiasis Treatment by Diagnostic Procedure - Cholangiography Diagnostic Procedure, MRI Diagnostic Procedure, Ultrasonography Diagnostic Procedure, CT scan Diagnostic Procedure and Other Diagnostic Procedures - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Iran Historic Review for Opisthorchiasis Treatment by Diagnostic Procedure - Cholangiography Diagnostic Procedure, MRI Diagnostic Procedure, Ultrasonography Diagnostic Procedure, CT scan Diagnostic Procedure and Other Diagnostic Procedures Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR

Iran 16-Year Perspective for Opisthorchiasis Treatment by Diagnostic Procedure - Percentage Breakdown of Value Sales for Cholangiography Diagnostic Procedure, MRI Diagnostic Procedure, Ultrasonography Diagnostic Procedure, CT scan Diagnostic Procedure and Other Diagnostic Procedures for the Years 2014, 2025 & 2030

ISRAEL

Israel Recent Past, Current & Future Analysis for Opisthorchiasis Treatment by Type - Medications Type and Surgery Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Israel Historic Review for Opisthorchiasis Treatment by Type - Medications Type and Surgery Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR

Israel 16-Year Perspective for Opisthorchiasis Treatment by Type - Percentage Breakdown of Value Sales for Medications Type and Surgery Type for the Years 2014, 2025 & 2030

Israel Recent Past, Current & Future Analysis for Opisthorchiasis Treatment by Symptom - Fever Symptom, Splenomegaly Symptom, Weight loss Symptom, Tachycardia Symptom, Other Symptoms, Jaundice Symptom and Diarrhea Symptom - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Israel Historic Review for Opisthorchiasis Treatment by Symptom - Fever Symptom, Splenomegaly Symptom, Weight loss Symptom, Tachycardia Symptom, Other Symptoms, Jaundice Symptom and Diarrhea Symptom Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR

Israel 16-Year Perspective for Opisthorchiasis Treatment by Symptom - Percentage Breakdown of Value Sales for Fever Symptom, Splenomegaly Symptom, Weight loss Symptom, Tachycardia Symptom, Other Symptoms, Jaundice Symptom and Diarrhea Symptom for the Years 2014, 2025 & 2030

Israel Recent Past, Current & Future Analysis for Opisthorchiasis Treatment by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Israel Historic Review for Opisthorchiasis Treatment by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR

Israel 16-Year Perspective for Opisthorchiasis Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030

Israel Recent Past, Current & Future Analysis for Opisthorchiasis Treatment by Diagnostic Procedure - Cholangiography Diagnostic Procedure, MRI Diagnostic Procedure, Ultrasonography Diagnostic Procedure, CT scan Diagnostic Procedure and Other Diagnostic Procedures - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Israel Historic Review for Opisthorchiasis Treatment by Diagnostic Procedure - Cholangiography Diagnostic Procedure, MRI Diagnostic Procedure, Ultrasonography Diagnostic Procedure, CT scan Diagnostic Procedure and Other Diagnostic Procedures Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR

Israel 16-Year Perspective for Opisthorchiasis Treatment by Diagnostic Procedure - Percentage Breakdown of Value Sales for Cholangiography Diagnostic Procedure, MRI Diagnostic Procedure, Ultrasonography Diagnostic Procedure, CT scan Diagnostic Procedure and Other Diagnostic Procedures for the Years 2014, 2025 & 2030

SAUDI ARABIA

Saudi Arabia Recent Past, Current & Future Analysis for Opisthorchiasis Treatment by Type - Medications Type and Surgery Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Saudi Arabia Historic Review for Opisthorchiasis Treatment by Type - Medications Type and Surgery Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR

Saudi Arabia 16-Year Perspective for Opisthorchiasis Treatment by Type - Percentage Breakdown of Value Sales for Medications Type and Surgery Type for the Years 2014, 2025 & 2030

Saudi Arabia Recent Past, Current & Future Analysis for Opisthorchiasis Treatment by Symptom - Fever Symptom, Splenomegaly Symptom, Weight loss Symptom, Tachycardia Symptom, Other Symptoms, Jaundice Symptom and Diarrhea Symptom - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Saudi Arabia Historic Review for Opisthorchiasis Treatment by Symptom - Fever Symptom, Splenomegaly Symptom, Weight loss Symptom, Tachycardia Symptom, Other Symptoms, Jaundice Symptom and Diarrhea Symptom Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR

Saudi Arabia 16-Year Perspective for Opisthorchiasis Treatment by Symptom - Percentage Breakdown of Value Sales for Fever Symptom, Splenomegaly Symptom, Weight loss Symptom, Tachycardia Symptom, Other Symptoms, Jaundice Symptom and Diarrhea Symptom for the Years 2014, 2025 & 2030

Saudi Arabia Recent Past, Current & Future Analysis for Opisthorchiasis Treatment by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Saudi Arabia Historic Review for Opisthorchiasis Treatment by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR

Saudi Arabia 16-Year Perspective for Opisthorchiasis Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030

Saudi Arabia Recent Past, Current & Future Analysis for Opisthorchiasis Treatment by Diagnostic Procedure - Cholangiography Diagnostic Procedure, MRI Diagnostic Procedure, Ultrasonography Diagnostic Procedure, CT scan Diagnostic Procedure and Other Diagnostic Procedures - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Saudi Arabia Historic Review for Opisthorchiasis Treatment by Diagnostic Procedure - Cholangiography Diagnostic Procedure, MRI Diagnostic Procedure, Ultrasonography Diagnostic Procedure, CT scan Diagnostic Procedure and Other Diagnostic Procedures Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR

Saudi Arabia 16-Year Perspective for Opisthorchiasis Treatment by Diagnostic Procedure - Percentage Breakdown of Value Sales for Cholangiography Diagnostic Procedure, MRI Diagnostic Procedure, Ultrasonography Diagnostic Procedure, CT scan Diagnostic Procedure and Other Diagnostic Procedures for the Years 2014, 2025 & 2030

UNITED ARAB EMIRATES

UAE Recent Past, Current & Future Analysis for Opisthorchiasis Treatment by Type - Medications Type and Surgery Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

UAE Historic Review for Opisthorchiasis Treatment by Type - Medications Type and Surgery Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR

UAE 16-Year Perspective for Opisthorchiasis Treatment by Type - Percentage Breakdown of Value Sales for Medications Type and Surgery Type for the Years 2014, 2025 & 2030

UAE Recent Past, Current & Future Analysis for Opisthorchiasis Treatment by Symptom - Fever Symptom, Splenomegaly Symptom, Weight loss Symptom, Tachycardia Symptom, Other Symptoms, Jaundice Symptom and Diarrhea Symptom - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

UAE Historic Review for Opisthorchiasis Treatment by Symptom - Fever Symptom, Splenomegaly Symptom, Weight loss Symptom, Tachycardia Symptom, Other Symptoms, Jaundice Symptom and Diarrhea Symptom Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR

UAE 16-Year Perspective for Opisthorchiasis Treatment by Symptom - Percentage Breakdown of Value Sales for Fever Symptom, Splenomegaly Symptom, Weight loss Symptom, Tachycardia Symptom, Other Symptoms, Jaundice Symptom and Diarrhea Symptom for the Years 2014, 2025 & 2030

UAE Recent Past, Current & Future Analysis for Opisthorchiasis Treatment by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

UAE Historic Review for Opisthorchiasis Treatment by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR

UAE 16-Year Perspective for Opisthorchiasis Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030

UAE Recent Past, Current & Future Analysis for Opisthorchiasis Treatment by Diagnostic Procedure - Cholangiography Diagnostic Procedure, MRI Diagnostic Procedure, Ultrasonography Diagnostic Procedure, CT scan Diagnostic Procedure and Other Diagnostic Procedures - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

UAE Historic Review for Opisthorchiasis Treatment by Diagnostic Procedure - Cholangiography Diagnostic Procedure, MRI Diagnostic Procedure, Ultrasonography Diagnostic Procedure, CT scan Diagnostic Procedure and Other Diagnostic Procedures Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR

UAE 16-Year Perspective for Opisthorchiasis Treatment by Diagnostic Procedure - Percentage Breakdown of Value Sales for Cholangiography Diagnostic Procedure, MRI Diagnostic Procedure, Ultrasonography Diagnostic Procedure, CT scan Diagnostic Procedure and Other Diagnostic Procedures for the Years 2014, 2025 & 2030

REST OF MIDDLE EAST

Rest of Middle East Recent Past, Current & Future Analysis for Opisthorchiasis Treatment by Type - Medications Type and Surgery Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Rest of Middle East Historic Review for Opisthorchiasis Treatment by Type - Medications Type and Surgery Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR

Rest of Middle East 16-Year Perspective for Opisthorchiasis Treatment by Type - Percentage Breakdown of Value Sales for Medications Type and Surgery Type for the Years 2014, 2025 & 2030

Rest of Middle East Recent Past, Current & Future Analysis for Opisthorchiasis Treatment by Symptom - Fever Symptom, Splenomegaly Symptom, Weight loss Symptom, Tachycardia Symptom, Other Symptoms, Jaundice Symptom and Diarrhea Symptom - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Rest of Middle East Historic Review for Opisthorchiasis Treatment by Symptom - Fever Symptom, Splenomegaly Symptom, Weight loss Symptom, Tachycardia Symptom, Other Symptoms, Jaundice Symptom and Diarrhea Symptom Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR

Rest of Middle East 16-Year Perspective for Opisthorchiasis Treatment by Symptom - Percentage Breakdown of Value Sales for Fever Symptom, Splenomegaly Symptom, Weight loss Symptom, Tachycardia Symptom, Other Symptoms, Jaundice Symptom and Diarrhea Symptom for the Years 2014, 2025 & 2030

Rest of Middle East Recent Past, Current & Future Analysis for Opisthorchiasis Treatment by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Rest of Middle East Historic Review for Opisthorchiasis Treatment by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR

Rest of Middle East 16-Year Perspective for Opisthorchiasis Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030

Rest of Middle East Recent Past, Current & Future Analysis for Opisthorchiasis Treatment by Diagnostic Procedure - Cholangiography Diagnostic Procedure, MRI Diagnostic Procedure, Ultrasonography Diagnostic Procedure, CT scan Diagnostic Procedure and Other Diagnostic Procedures - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Rest of Middle East Historic Review for Opisthorchiasis Treatment by Diagnostic Procedure - Cholangiography Diagnostic Procedure, MRI Diagnostic Procedure, Ultrasonography Diagnostic Procedure, CT scan Diagnostic Procedure and Other Diagnostic Procedures Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR

Rest of Middle East 16-Year Perspective for Opisthorchiasis Treatment by Diagnostic Procedure - Percentage Breakdown of Value Sales for Cholangiography Diagnostic Procedure, MRI Diagnostic Procedure, Ultrasonography Diagnostic Procedure, CT scan Diagnostic Procedure and Other Diagnostic Procedures for the Years 2014, 2025 & 2030

AFRICA

Opisthorchiasis Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)

Africa Recent Past, Current & Future Analysis for Opisthorchiasis Treatment by Type - Medications Type and Surgery Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Africa Historic Review for Opisthorchiasis Treatment by Type - Medications Type and Surgery Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR

Africa 16-Year Perspective for Opisthorchiasis Treatment by Type - Percentage Breakdown of Value Sales for Medications Type and Surgery Type for the Years 2014, 2025 & 2030

Africa Recent Past, Current & Future Analysis for Opisthorchiasis Treatment by Symptom - Fever Symptom, Splenomegaly Symptom, Weight loss Symptom, Tachycardia Symptom, Other Symptoms, Jaundice Symptom and Diarrhea Symptom - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Africa Historic Review for Opisthorchiasis Treatment by Symptom - Fever Symptom, Splenomegaly Symptom, Weight loss Symptom, Tachycardia Symptom, Other Symptoms, Jaundice Symptom and Diarrhea Symptom Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR

Africa 16-Year Perspective for Opisthorchiasis Treatment by Symptom - Percentage Breakdown of Value Sales for Fever Symptom, Splenomegaly Symptom, Weight loss Symptom, Tachycardia Symptom, Other Symptoms, Jaundice Symptom and Diarrhea Symptom for the Years 2014, 2025 & 2030

Africa Recent Past, Current & Future Analysis for Opisthorchiasis Treatment by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Africa Historic Review for Opisthorchiasis Treatment by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR

Africa 16-Year Perspective for Opisthorchiasis Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030

Africa Recent Past, Current & Future Analysis for Opisthorchiasis Treatment by Diagnostic Procedure - Cholangiography Diagnostic Procedure, MRI Diagnostic Procedure, Ultrasonography Diagnostic Procedure, CT scan Diagnostic Procedure and Other Diagnostic Procedures - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR

Africa Historic Review for Opisthorchiasis Treatment by Diagnostic Procedure - Cholangiography Diagnostic Procedure, MRI Diagnostic Procedure, Ultrasonography Diagnostic Procedure, CT scan Diagnostic Procedure and Other Diagnostic Procedures Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR

Africa 16-Year Perspective for Opisthorchiasis Treatment by Diagnostic Procedure - Percentage Breakdown of Value Sales for Cholangiography Diagnostic Procedure, MRI Diagnostic Procedure, Ultrasonography Diagnostic Procedure, CT scan Diagnostic Procedure and Other Diagnostic Procedures for the Years 2014, 2025 & 2030

COMPETITIVE METRICS

COMPETITORS (ALPHABETICAL)	% VALIDATED RESEARCH *

* Login to Participate & View Data Stacks

* Participating executives must be from a competitive company. Executive credentials are validated by a one-time two-factor authentication, in compliance with GDPR guidelines. Verified executives have complimentary access to our proprietary MarketGlass^TM platform and relevant data silos including Trend Data; Brand/IP/TM Feeds; and Market Size, Share & Rank Clusters. Qualified influencers are also invited to join our Expert Panels. Privileges include purchase credits, and collaborative bespoke builds.

View All Companies...

PARTICIPATE NOW!

PREVIEW REPORT

YOUR PRIVACY MATTERS!

Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.

What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: [email protected]

DIFFERENTIATORS

Integrity Trust Transparency

Our research offerings primarily draw upon unique perspectives of participating executives and their experiences in operating and strategy roles. These geo-focused insights enrich our projects .

What we are NOT - Our reports are not editorial exercises of remote analysts’ secondary source fed content that predominantly flood today’s off-the-shelf market report business. (A review of 262 publishers).

WHAT SETS US APART

FULL STACK DATA ACCESS

Primary Research Cluster Data
Influencer Engagement Stats
Evidence of Primary Research
List of Companies Engaged
Hundreds of Pages of Research
Peer Collaborative Interactions
Enterprise Data Exchanges
MarketGlassTM Platform Insider
Geographic Pricing Dynamics
Competitive Shares by Country
Brand Curation & Insights
Domain Expert Pool

Program Transparency: Clients have access to engagement stats of companies and executives. Clients may commission third-party audits of our influencer engagements at their expense.

Primary Research: We have a very successful incentive driven primary research program presenting a rich experience to participating executives. Featured company executives can sign up for a complimentary.

Collaborative Intelligence: Our platform presents a unique features for executives to collaborate with peers across geographies and participate on various product or regional perspectives for a collective unified insider project experience.

Global Brand Intelligence: We present competitive brand intelligence at the company level for players worldwide. Executives from brand owner companies participate to curate each brand for relevance and market presence.

Bespoke Updates: Our peer-to-peer online interactive platform enables client companies to build upon our project data stacks to build bespoke editions for internal sharing and use. Client company can build one complimentary update per year and unlimited updates for additional fee. Bespoke updates are fulfilled within a two-day turnaround.

Enterprise EcoConnect: Discretely bounce off queries to participant pool of executives. We can reach out to our participant pool based on specifics of geographic or domain acumen.

Renowned Support: We pride in our commitment to provide support to our clients. We go beyond the scope of the study to get you timely answers.

Complimentary Updates: Unlike the industry’s published PDF’s that are frozen in time from date of release, our research programs are ongoing and dynamic. Our reports are updated whenever there’s a major event impacting the marketplace. Your license offers seamless updates for one year.

No Fluff: We offer our clients the best CX with clean easy to read content. No verbose fluff. We offer clients full access to the entire stack of hundreds of pages of secondary research feeds used in our project via our online MarketGlass portal.

Scroll